Clinical study of eliminating dampness and phlegm treatment for angina pectoris after revascularization of coronary heart disease
- Conditions
- coronary heart disease
- Registration Number
- ITMCTR2000004085
- Lead Sponsor
- Guangdong Provincial Hospital of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1 Age over 18 years;
2 Percutaneous transluminal coronary angioplasty (PTCA) or stent implantation was performed within 1 year
3 2<= rSS Score;
4 consent to Myocardial Contrast Echocardiography;
5 informed consent.
CARDIOGENIC shock; severe heart failure (Grade IV cardiac function, or lvef <= 40%); patients with severe valvular heart disease; severe hepatic and Renal Impairment (Serum Alanine transaminase > 3 times normal upper limit and/or serum Creatinine >= 265umol/l) ; Patients with acute cerebrovascular disease or severe mental illness; women with active bleeding or severe hematopoietic disorders; Malignant neoplasms or patients with a life expectancy of less than 3 years; women who are pregnant or preparing for pregnancy; women who are breastfeeding; Those who have participated in or are participating in other clinical trials within the last three months; those who refuse to sign an informed consent form, or who have poor adherence and poor likelihood of follow-up.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Myocardial blood flow;Myocardial blood volume;
- Secondary Outcome Measures
Name Time Method